Photo of Vijayalakshmi Shridhar

View Scopus Profile

Vijayalakshmi Shridhar, PhD

  • 7597 Citations
  • 47 Scopus h-Index
1976 …2020

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Vijayalakshmi Shridhar is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 4 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects

Poisoning of PARP and Topoisomerase I to Treat Ovarian Cancer

Kaufmann, S. H., Cliby, W. A., Bible, K. C., Goode, E. L., Galanis, E., Knutson, K. L., Hartmann, L. C., Oberg, A. L., Couch, F. J., Fields, A. P., Haluska, P. R. J., Long, H., Bell, D., Keeney, G., Lengyel, E., Keeney, G., Shridhar, V., Cliby, W. A., Goode, E. L., Peng, K., Hartmann, L. C. & Lingle, W. L.

National Institutes of Health

10/1/08 → 8/31/20

Project: Research project

    • Regulation of Serine Protease HtrA1 and Chemoresponse

    Shridhar, V. & Chien, J.

    National Institutes of Health

    4/1/08 → 1/31/14

    Project: Research project

    • Role of HSulf-1 Loss in Apoptosis and Drug Resistance

    Shridhar, V.

    National Institutes of Health

    3/1/04 → 2/28/09

    Project: Research project

    • Research Output

    • 7597 Citations
    • 47 Scopus h-Index
    • 132 Article
    • 5 Comment/debate
    • 4 Review article
    • 3 Chapter

    Coiled-Coil and C2 Domain-Containing Protein 1A (CC2D1A) Promotes Chemotherapy Resistance in Ovarian Cancer

    Kumar, S., Oien, D. B., Khurana, A., Cliby, W., Hartmann, L., Chien, J. & Shridhar, V., Oct 1 2019, In : Frontiers in Oncology. 9, 986.

    Research output: Contribution to journal › Article

    Open Access

    • Correction: The heparan sulfate mimetic PG545 interferes with Wnt/β-catenin signaling and significantly suppresses pancreatic tumorigenesis alone and in combination with gemcitabine (Oncotarget (2015) 6 (4992–5004) DOI: 10.18632/oncotarget.3214)

    Jung, D. B., Yun, M., Kim, E. O., Kim, J., Kim, B., Jung, J. H., Wang, E., Mukhopadhyay, D., Hammond, E., Dredge, K., Shridhar, V. & Kim, S. H., Sep 1 2019, In : Oncotarget. 10, 54, 1 p.

    Research output: Contribution to journal › Comment/debate

    Open Access

    • Genes associated with bowel metastases in ovarian cancer

    Mariani, A., Wang, C., Oberg, A. L., Riska, S. M., Torres, M., Kumka, J., Multinu, F., Sagar, G., Roy, D., Jung, DB. B., Zhang, Q., Grassi, T., Visscher, D. W., Patel, V. P., Jin, L., Staub, J. K., Cliby, W. A., Weroha, S. J., Kalli, K. R., Hartmann, L. C. & 3 others, Kaufmann, S. H., Goode, E. L. & Shridhar, V., Jan 1 2019, In : Gynecologic oncology.

    Research output: Contribution to journal › Article

    Open Access
    • 3 Scopus citations

    PFKFB3 inhibition reprograms malignant pleural mesothelioma to nutrient stress-induced macropinocytosis and ER stress as independent binary adaptive responses

    Sarkar Bhattacharya, S., Thirusangu, P., Jin, L., Roy, D., Jung, D., Xiao, Y., Staub, J., Roy, B., Molina, J. R. & Shridhar, V., Oct 1 2019, In : Cell Death and Disease. 10, 10, 725.

    Research output: Contribution to journal › Article

    Open Access
    • 1 Scopus citations

    Repurposing quinacrine for treatment-refractory cancer

    Oien, D. B., Pathoulas, C. L., Ray, U., Thirusangu, P., Kalogera, E. & Shridhar, V., Jan 1 2019, (Accepted/In press) In : Seminars in Cancer Biology.

    Research output: Contribution to journal › Review article

    Open Access
    • 1 Scopus citations